
 | Webcast Q4 2011 Hospira Earnings Conference Call (Live) 02/14/12 at 8:00 a.m. CT |
Corporate Profile Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately 14,000 employees worldwide. In 2010, Hospira generated approximately $3.9 billion in sales. To learn more, click here. Exchange
The common stock is listed on the New York Stock Exchange under the symbol "HSP."
Transfer Agent
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078
800-821-1238
www.computershare.com https://www-us.computershare.com/investor/contactus
Hospira Mailing Address: Hospira, Inc. 275 North Field Drive Dept. 051M, Bldg. H1-2S Lake Forest, IL 60045 Shareholder E-Delivery Are you a Hospira shareholder? If so, you can elect to receive your annual report, proxy statement and other investor-related materials online, reducing the amount of mailings you receive from us. Using Shareholder E-Delivery also promotes less paper usage, a more environmentally friendly practice, and helps reduce company costs. If this is an option that interests you, sign up today! |
|